
E-Eye: Dry Eye Pulsed Light Technology
E-Eye device it's an innovative device that uses Intense Pulsed Light (IPL) to treat Meibomian Gland Dysfunction (MGD), the main cause of Dry Eye Syndrome..
With precisely calibrated and sequenced pulse emission technology, it stimulates the glands to resume their natural function, reducing tear evaporation and providing long-lasting relief.
The E-Eye device marks a revolution in dry eye treatment, offering an effective and affordable solution for patients who suffer from this problem on a daily basis.
Rediscover vision comfort with E-Eye.
Main Advantages:
✔ Fast, non-invasive treatment: sessions take just a few minutes
✔ Proven results: 90% of the patients reported improvement from the first sessions
✔ Effective protocol: 3 initial sessions (days 0, 15 and 45), with the option of boosters
✔ Safety and comfort: painless method and no need for recovery
E-Eye device it's an innovative device that uses Intense Pulsed Light (IPL) to treat Meibomian Gland Dysfunction (MGD), the main cause of Dry Eye Syndrome..
With precisely calibrated and sequenced pulse emission technology, it stimulates the glands to resume their natural function, reducing tear evaporation and providing long-lasting relief.
The E-Eye device marks a revolution in dry eye treatment, offering an effective and affordable solution for patients who suffer from this problem on a daily basis.
Rediscover vision comfort with E-Eye.
Main Advantages:
✔ Fast, non-invasive treatment: sessions take just a few minutes
✔ Proven results: 90% of the patients reported improvement from the first sessions
✔ Effective protocol: 3 initial sessions (days 0, 15 and 45), with the option of boosters
✔ Safety and comfort: painless method and no need for recovery
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
goldfarma © 2025 all rights reserved